MTPC Sets Up External Committee to Promote Appropriate Use of Telavic

Mitsubishi Tanabe Pharma Corporation (MTPC) revealed on December 7 that it has set up an external committee of specialist doctors to promote the appropriate use of Telavic (telaprevir), which it launched last month for chronic hepatitis C. The committee will...read more